Pharmaceutical manufacturer
H.R. 5397, Joe Fiandra Access to Home Infusion Act of 2023, issues related to Medicare coverage of home infusion; issues related to the implementation of the Inflation Reduction Act; H.R. 5539/S.3131, ORPHAN Cures Act; S. 476/H.R. 5547, Maintaining Investments in New Innovation Act
MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ALNYLAM PHARMACEUTICALS, INC.
675 West Kendall Street, Cambridge, MA, 02142, US
DEIRDRE BRADFORD PARSONS